Next Generation Sequencing Analysis of Breast Cancer Cell Line MCF-7 And MDA-MB-231 After PI3K Inhibition
RNA-seq (gene expression) · human · 12 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Breast cancerThis series is part of our curated briefing on it.
- Samples
- 12 samples: 3 × MCF-7 treated with DMSO vs 3 × MCF-7 treated with GDC-0941 vs 3 × MDA-MB-231 treated with DMSO vs 3 × MDA-MB-231 treated with GDC-0941Groups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Persistent PI3K-AKT signaling fortifies cellular defense against oxidative stress and ferroptosis through augmented mitochondrial fitnessCellular & molecular biology letters · 2026
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE221833_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA916266 and SRA study SRP414953. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 12 samples.
How we read this: 4 replicated groups read from 12 sample titles; they account for 12 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM6900415 MCF-7 treated with DMSO_1 MCF-7 treated with DMSO
- GSM6900416 MCF-7 treated with DMSO_2 MCF-7 treated with DMSO
- GSM6900417 MCF-7 treated with DMSO_3 MCF-7 treated with DMSO
- GSM6900418 MCF-7 treated with GDC-0941_1 MCF-7 treated with GDC-…
- GSM6900419 MCF-7 treated with GDC-0941_2 MCF-7 treated with GDC-…
- GSM6900420 MCF-7 treated with GDC-0941_3 MCF-7 treated with GDC-…
- GSM6900421 MDA-MB-231 treated with DMSO_1 MDA-MB-231 treated with…
- GSM6900422 MDA-MB-231 treated with DMSO_2 MDA-MB-231 treated with…
- GSM6900423 MDA-MB-231 treated with DMSO_3 MDA-MB-231 treated with…
- GSM6900424 MDA-MB-231 treated with GDC-0941_1 MDA-MB-231 treated with…
- GSM6900425 MDA-MB-231 treated with GDC-0941_2 MDA-MB-231 treated with…
- GSM6900426 MDA-MB-231 treated with GDC-0941_3 MDA-MB-231 treated with…
- GSE104193 Hypoxia-mediated translational activation of ITGB3 in breast cancer cells enhances TGF-β signalling and malignant features in vitro and in vivo 32 samples same disease briefing · shares breast
- GSE104675 Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 6 samples same disease briefing · shares breast
- GSE10886 A Supervised Risk Predictor of Breast Cancer Based on Biological Subtypes 226 samples same disease briefing · shares breast
- GSE11121 The humoral immune system has a key prognostic impact in node-negative breast cancer 200 samples same disease briefing · shares breast
- GSE10885 An integromic analysis reveals that metaplastic carcinomas are distinct from basal-like tumors. 244 samples same disease briefing
- GSE319124 Next-GenerationPediatric Cancer Models: Patient-Matched Orthotopic Xenografts, 3D Organoids, 2D Cultures, and Cell Lines for Identification of Therapeutic Vulnerabilities in Pediatric Solid Tumors [scRNAseq] 59 samples shares generation, next, line
- GSE285448 Next Generation sequencing Facilitates Quantitative Analysis of α-KG and control Transcriptomes in MKN74 and AGS cell lines 12 samples shares generation, next, line
- GSE237512 PI3Kα inhibition blocks osteochondroprogenitor specification and the hyper-inflammatory response to prevent heterotopic ossification 39 samples shares pi3k, inhibition
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.